On April 20th, 2024, Serum Institute of India PVT. LTD hosted a crucial seminar focusing on cervical cancer and HPV vaccination in T. & T.V. Institute of Nursing, Surat. The event aimed to raise awareness about the importance of cervical cancer prevention and the role of HPV vaccination in reducing its incidence. Student of both GNM & B.Sc. Nursing courses attend seminar to enhance their knowledge and stay updated with the latest developments in the health care sector. Seminars provide valuable opportunities for learning. networking and professional development. Experts in the field discussed the prevalence of cervical cancer, its risk factors, and the significance of early detection through regular screenings. They discussed topic such as Human papillomavirus (HPV) vaccination, Cervical cancer and relationship between HPV vaccination and cervical cancer. Human papillomavirus (HPV) vaccination is a preventive measure aimed at reducing the risk of HPV infections, which are strongly associated with cervical cancer and other types of cancer. Here is a detailed report on HPV vaccination and its relationship to cervical cancer:
- HPV Vaccination:
HPV vaccines are designed to protect against infection with certain types of HPV known to cause cervical cancer, as well as other HPV-related cancers and genital warts. The vaccines are typically administered in a series of shots over several months, usually starting at ages 11- 12, but can be given as early as age 9 and up to age 26 for females and age 21 for males. There are several HPV vaccines available, including Gardasil 9, which protects against nine types of HPV, and Cervarix, which protects against two types. The vaccines are highly effective in preventing HPV infections and related diseases when given before exposure to the virus through sexual activity.
- Cervical Cancer:
Cervical cancer is one of the most common cancers among women worldwide, with HPV infection being the primary risk factor. Persistent infection with certain high-risk HPV types, particularly HPV 16 and HPV 18, can lead to the development of cervical cancer. Other risk factors for cervical cancer include smoking, weakened immune system, early sexual activity, multiple sexual partners, and a history of sexually transmitted infections. Regular screening tests, such as Pap tests and HPV tests, can detect these changes early, allowing for timely intervention and treatment. Symptoms of cervical cancer may include abnormal vaginal bleeding, pelvic pain, pain during intercourse, and abnormal vaginal discharge, but these symptoms may not appear until the cancer has advanced.
3. Relationship between HPV Vaccination and Cervical Cancer:
HPV vaccination significantly reduces the risk of HPV infection and the subsequent development of cervical cancer and other HPV-related cancers. Studies have shown that HPV Vaccination can prevent up to 90% of cervical cancers, as well as a significant proportion of other HPV-related cancers and genital warts. Vaccination is most effective when administered before exposure to HPV through sexual activity, which is why it is recommended for preadolescents and young adults. Vaccination does not treat existing HPV infections or HPV- related diseases, so it’s essential for individuals who are eligible for vaccination to receive it before becoming sexually active. Despite the proven effectiveness of HPV vaccination, vaccination rates vary globally, and efforts to increase vaccine uptake among eligible populations are ongoing.
In conclusion, HPV vaccination is a crucial strategy for preventing HPV infections and reducing the incidence of cervical cancer and other HPV-related cancers. It is recommended as part of routine immunization programs for adolescents and young adults, and its widespread adoption can have a significant impact on public health by reducing the burden of HPV-related diseases. Regular cervical cancer screening remains important for early detection and treatment of precancerous changes and cervical cancer, even among vaccinated individuals. They emphasized the effectiveness of HPV vaccination in preventing certain strains of the virus known to cause cervical cancer. Attendees had the opportunity to ask questions and engage in discussions, empowering them with knowledge to make informed decisions about their health. Overall, the seminar provided valuable insights and sparked conversations about women’s health and preventive measures against cervical cancer.
During the seminar, attendees were assured of access to HPV vaccination at minimal charges, underscoring the commitment of the college to prioritize the health and well-being of its students and staff. This initiative aimed to make the vaccine more accessible and affordable, thereby encouraging more individuals to avail themselves of this preventive measure against cervical cancer. At the conclusion of the seminar, attendees were provided with an information booklet containing comprehensive details about cervical cancer, HPV vaccination, and preventive measures. This booklet served as a valuable resource, offering in-depth information about the importance of vaccination, screening guidelines, and ways to reduce the risk of cervical cancer. By distributing this resource, the college aimed to ensure that participants had access to reliable information even after the seminar, empowering them to make informed decisions about their health. This initiative underscored the college’s commitment to promoting
health education and empowering individuals to take proactive steps towards preventing cervical cancer.
In closing, the principal sir expressed gratitude to the experts for sharing their expertise and insights, recognizing the invaluable contribution of their knowledge in educating the students about cervical cancer prevention. The gesture highlighted the collaborative effort. between the college administration and health professionals to promote public health initiatives and empower individuals to take proactive steps towards safeguarding their health.
